147 related articles for article (PubMed ID: 24041887)
1. Tissue pharmacokinetics of cefazolin in patients with lower limb infections.
Bhalodi AA; Housman ST; Shepard A; Nugent J; Nicolau DP
Antimicrob Agents Chemother; 2013 Nov; 57(11):5679-83. PubMed ID: 24041887
[TBL] [Abstract][Full Text] [Related]
2. Vancomycin Tissue Pharmacokinetics in Patients with Lower-Limb Infections via In Vivo Microdialysis.
Housman ST; Bhalodi AA; Shepard A; Nugent J; Nicolau DP
J Am Podiatr Med Assoc; 2015 Sep; 105(5):381-8. PubMed ID: 26429605
[TBL] [Abstract][Full Text] [Related]
3. Physiological modeling for indirect evaluation of drug tissular pharmacokinetics under non-steady-state conditions: an example of antimicrobial prophylaxis during liver surgery.
Lagneau F; Marty J; Beyne P; Tod M
J Pharmacokinet Pharmacodyn; 2005 Feb; 32(1):1-32. PubMed ID: 16175313
[TBL] [Abstract][Full Text] [Related]
4. Tissue penetration and pharmacokinetics of tigecycline in diabetic patients with chronic wound infections described by using in vivo microdialysis.
Bulik CC; Wiskirchen DE; Shepard A; Sutherland CA; Kuti JL; Nicolau DP
Antimicrob Agents Chemother; 2010 Dec; 54(12):5209-13. PubMed ID: 20921312
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetics of cefazolin in critically ill children infected with methicillin-sensitive Staphylococcus aureus.
Salvador E; Oualha M; Bille E; Beranger A; Moulin F; Benaboud S; Boujaafar S; Gana I; Urien S; Zheng Y; Toubiana J; Briand C; Bustarret O; Geslain G; Renolleau S; Treluyer JM; Hirt D
Clin Microbiol Infect; 2021 Mar; 27(3):413-419. PubMed ID: 32360445
[TBL] [Abstract][Full Text] [Related]
6. Skeletal muscle and plasma concentrations of cefazolin during cardiac surgery in infants.
Himebauch AS; Nicolson SC; Sisko M; Moorthy G; Fuller S; Gaynor JW; Zuppa AF; Fox E; Kilbaugh TJ
J Thorac Cardiovasc Surg; 2014 Dec; 148(6):2634-41. PubMed ID: 25131168
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of intermittent intravenous cefazolin and tobramycin in patients treated with automated peritoneal dialysis.
Manley HJ; Bailie GR; Frye R; Hess LD; McGoldrick MD
J Am Soc Nephrol; 2000 Jul; 11(7):1310-1316. PubMed ID: 10864588
[TBL] [Abstract][Full Text] [Related]
8. Reduced subcutaneous tissue distribution of cefazolin in morbidly obese versus non-obese patients determined using clinical microdialysis.
Brill MJ; Houwink AP; Schmidt S; Van Dongen EP; Hazebroek EJ; van Ramshorst B; Deneer VH; Mouton JW; Knibbe CA
J Antimicrob Chemother; 2014 Mar; 69(3):715-23. PubMed ID: 24214905
[TBL] [Abstract][Full Text] [Related]
9. Population Pharmacokinetics of Cefazolin in Serum and Adipose Tissue From Overweight and Obese Women Undergoing Cesarean Delivery.
Grupper M; Kuti JL; Swank ML; Maggio L; Hughes BL; Nicolau DP
J Clin Pharmacol; 2017 Jun; 57(6):712-719. PubMed ID: 27925657
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of topical and intravenous cefazolin in patients with clean surgical wounds.
White RR; Pitzer KD; Fader RC; Rajab MH; Song J
Plast Reconstr Surg; 2008 Dec; 122(6):1773-1779. PubMed ID: 19050530
[TBL] [Abstract][Full Text] [Related]
11. Are bone and serum cefazolin concentrations adequate for antimicrobial prophylaxis?
Yamada K; Matsumoto K; Tokimura F; Okazaki H; Tanaka S
Clin Orthop Relat Res; 2011 Dec; 469(12):3486-94. PubMed ID: 21968901
[TBL] [Abstract][Full Text] [Related]
12. Cefazolin and linezolid penetration into sternal cancellous bone during coronary artery bypass grafting.
Andreas M; Zeitlinger M; Wisser W; Jaeger W; Maier-Salamon A; Thalhammer F; Kocher A; Hiesmayr JM; Laufer G; Hutschala D
Eur J Cardiothorac Surg; 2015 Nov; 48(5):758-64. PubMed ID: 25527166
[TBL] [Abstract][Full Text] [Related]
13. Population Pharmacokinetics of Cefazolin in Serum and Tissue for Patients with Complicated Skin and Soft Tissue Infections (cSSTI).
So W; Kuti JL; Nicolau DP
Infect Dis Ther; 2014 Dec; 3(2):269-79. PubMed ID: 25410773
[TBL] [Abstract][Full Text] [Related]
14. Humanized tissue pharmacodynamics of cefazolin against commonly isolated pathogens in skin and skin structure infections.
Jain JG; Housman ST; Nicolau DP
J Antimicrob Chemother; 2014 Sep; 69(9):2443-7. PubMed ID: 24827890
[TBL] [Abstract][Full Text] [Related]
15. Intravenous cefazolin in penetrating eye injuries. A swine model.
Nossov PC; Alfaro DV; Michaud ME; Winter LW; Laughlin RM; Moss ST
Retina; 1996; 16(3):246-9. PubMed ID: 8789865
[TBL] [Abstract][Full Text] [Related]
16. In vitro pharmacodynamics of vancomycin and cefazolin alone and in combination against methicillin-resistant Staphylococcus aureus.
Hagihara M; Wiskirchen DE; Kuti JL; Nicolau DP
Antimicrob Agents Chemother; 2012 Jan; 56(1):202-7. PubMed ID: 22006007
[TBL] [Abstract][Full Text] [Related]
17. Optimal Cefazolin Prophylactic Dosing for Bariatric Surgery: No Need for Higher Doses or Intraoperative Redosing.
Chen X; Brathwaite CE; Barkan A; Hall K; Chu G; Cherasard P; Wang S; Nicolau DP; Islam S; Cunha BA
Obes Surg; 2017 Mar; 27(3):626-629. PubMed ID: 27520693
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and protein binding of cefazolin in morbidly obese patients.
van Kralingen S; Taks M; Diepstraten J; van de Garde EM; van Dongen EP; Wiezer MJ; van Ramshorst B; Vlaminckx B; Deneer VH; Knibbe CA
Eur J Clin Pharmacol; 2011 Oct; 67(10):985-92. PubMed ID: 21499760
[TBL] [Abstract][Full Text] [Related]
19. Early Antibiotic Prophylaxis Prior to Bypass Surgery Improves Tissue Penetration.
Andreas M; Zeitlinger M; Shabanian S; Wisser W; Thell R; Edlinger-Stanger M; Maier-Salamon A; Jaeger W; Kocher A; Laufer G; Hiesmayr JM; Hutschala D
Thorac Cardiovasc Surg; 2020 Dec; 68(8):669-673. PubMed ID: 31491791
[TBL] [Abstract][Full Text] [Related]
20. High-Dosage Cefazolin Achieves Sufficient Cerebrospinal Diffusion To Treat an External Ventricular Drainage-Related
Grégoire M; Gaborit B; Deschanvres C; Lecomte R; Deslandes G; Dailly É; Ambrosi X; Bellouard R; Asseray N; Lakhal K; Boutoille D
Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30420481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
